11 beta, 17 alpha, 21-Trihydroxy-1,4-pregnadien-3,20-dion 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatriensäure ester]

11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the formula an antiinflammatory composition thereof and a method for the production thereof. 11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP, AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP, ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP, KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP, SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP, MIZUSHIMA, YUTAKA, TOKYO-TO, JP, KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP, NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP, IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP, INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP, HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP, YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the formula an antiinflammatory composition thereof and a method for the production thereof. 11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the present invention exhibits remarkably excellent antiinflammatory action and besides, displays reduced side effects and can be produced in high selectivity and good yield and conveniently.